What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Surgery
The scientist’s investigation covers issues in Internal medicine, Bacteremia, Microbiology, Mortality rate and Antibiotics.
His Internal medicine research integrates issues from Surgery and Intensive care medicine.
His studies deal with areas such as Pseudomonas aeruginosa, Ciprofloxacin, Antimicrobial and Carbapenem as well as Bacteremia.
His Microbiology research incorporates elements of Klebsiella pneumoniae and Epidemiology.
His Mortality rate study which covers Septic shock that intersects with Neutropenia.
His research integrates issues of Multiple drug resistance, Drug resistance and Streptococcus pneumoniae in his study of Antibiotic resistance.
His most cited work include:
- Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome (500 citations)
- Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome (401 citations)
- Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study (255 citations)
What are the main themes of his work throughout his whole career to date?
Cheol-In Kang mostly deals with Internal medicine, Microbiology, Bacteremia, Antibiotics and Surgery.
His Internal medicine study frequently links to adjacent areas such as Intensive care medicine.
The various areas that Cheol-In Kang examines in his Microbiology study include Klebsiella pneumoniae and Virology.
The study incorporates disciplines such as Ciprofloxacin, Antibacterial agent, Epidemiology, Escherichia coli and Pseudomonas aeruginosa in addition to Bacteremia.
Cheol-In Kang has included themes like Vancomycin and Methicillin-resistant Staphylococcus aureus in his Antibiotics study.
His Surgery research incorporates themes from Incidence and Cohort study.
He most often published in these fields:
- Internal medicine (43.56%)
- Microbiology (34.32%)
- Bacteremia (29.37%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (43.56%)
- Retrospective cohort study (13.86%)
- Antibiotics (16.17%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Retrospective cohort study, Antibiotics, Microbiology and Bacteremia.
His study in Odds ratio, Mortality rate, Confidence interval, Pneumonia and Cancer is carried out as part of his studies in Internal medicine.
His studies in Retrospective cohort study integrate themes in fields like Anesthesia, Minimum inhibitory concentration, Propensity score matching and Trough level.
His Antibiotics research is multidisciplinary, relying on both 16S ribosomal RNA, Urinary system and Enterobacteriaceae.
His Microbiology study combines topics from a wide range of disciplines, such as Multilocus sequence typing and Escherichia coli.
His biological study spans a wide range of topics, including Bloodstream infection, Liver transplantation, Klebsiella pneumoniae and Genotype.
Between 2017 and 2021, his most popular works were:
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience (166 citations)
- Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections. (51 citations)
- Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. (24 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Bacteria
His primary scientific interests are in Internal medicine, Bacteremia, Odds ratio, Mortality rate and Confidence interval.
Cheol-In Kang interconnects Candida glabrata and Non albicans candida in the investigation of issues within Internal medicine.
Cheol-In Kang incorporates Bacteremia and In patient in his research.
The concepts of his Mortality rate study are interwoven with issues in Sulfamethoxazole and Trimethoprim.
Cheol-In Kang combines subjects such as Endocarditis, Risk of mortality, Incidence and Staphylococcus aureus with his study of Confidence interval.
The Retrospective cohort study study which covers Pseudomonas aeruginosa that intersects with Antibiotic resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
